drugset / Trial / NCT06068439
Study of the Protective Effect of Low-dose Aspirin on Renal Function in Patients With Early Diabetic Nephropathy
Phase 2/3
Not yet recruiting
355 enrolled
Second Affiliated Hospital, School of Medicine, Zhejiang University
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a multicenter, randomized, placebo-controlled study to evaluate the effectiveness and safety of low-dose aspirin (50 mg/day) in renal and cardiac function protection in people with diabetic nephropathy.
Timeline
- Start
- 2024-01-01
- Primary completion
- 2027-01-30
- Completion
- 2027-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aspirin | Small molecule | 50 mg | — |